Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Portugal
Stock Information for Daxor Corporation
Please wait while we load your information from QuoteMedia.
More Recent News About Daxor Corporation
Alimera Sciences to Report First Quarter 2023 Financial Results on May 15, 2023, and Provide Corporate Update
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in the Nordic Countries